-
Can this test alone diagnose precisely without other tests?
MASTOCHECK demonstrates high accuracy on its own, and when performed in conjunction with mammography, it enhances the sensitivity of the test to 93.9%, with a recorded sensitivity of 93% even in dense breast (grade 3 and 4).
-
Is fasting required before the test?
MASTOCHECK analyzes proteins in the blood, and fasting is not required.
-
How does it differ from the genetic test?
Breast cancer genetic (BRCA 1, BRCA 1, etc.) test is not a test to evaluate the presence of breast cancer.
It specializes in predicting breast cancer risk and identifying the cause of the cancer
MASTOCHECK is a blood-based test that analyzes protein within the blood to identify the presence of breast cancer
-
Is MASTOCHECK a reliable test?
MASTOCHECK is a result of many years of clinical research done by the key opinion leader in breast oncology, Professor Dong Young Noh, and his team at Seoul National University in Korea.
It has been proven effective in the diagnosis of breast cancer in phases 0-2 and has received approval from the Ministry of Food and Drug Safety as an in vitro diagnostic medical device.
-
Besides breast cancer do other cancer types affect the test result?
Biomarkers for MASTOCHECK have almost no correlation with lung, stomach, liver, ovarian, uterus, colon, pancreatic cancer, and more.
The test specializes in diagnosing breast cancer by using breast cancer-specific biomarkers.
-
What is the recommended MASTOCHECK screening cycle?
We recommend patients to undergo MASTOCHECK screening annually, unless they are considered high risk due to personal or familial factors.
The one-year interval is recommended because proteins in the blood vary with lifestyle habits as well as with environmental factors.
-
Is it breast cancer, if the result comes out as ‘high-risk’?
MASTOCHECK is a breast screening test and not a biopsy.
In the case of a 'high-risk' result, it is recommended to consult with a medical professional and undergo additional follow-up screening.
